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1. Introduction 
This chapter concerns a new concept of innovation in healthcare technology. ISIFC is the 
internal engineering school of University of Besançon (France) and is accredited by the 
French Ministry of National Education. The « Institut supérieur d’ingénieurs de Franche-
Comté » (ISIFC) graduates 216 biomedical engineering students since 2004 for the 
prevention, diagnosis and treatment of disease, for patient rehabilitation and for improving 
health.  Its originality lies in its innovative course of studies, which trains engineers in the 
scientific and medical fields to get both competencies. The Institute therefore collaborates 
with the University Hospital Centre of Besançon (CHU), biomedical companies and 
National Research Centres (CNRS and INSERM). The teaching team consists mainly in 
lecturer-researchers and researchers as well as biomedical and health industry professionals. 
It’s an innovative engineering French school, which tries to understand the expectation of 
the specific healthcare and medical devices markets. It trains engineers in 3 years (2400 
hours per student) with a double culture, medical and technical, who will work for 80% in 
biomedical industry, 10% in healthcare centre and 5% in research laboratory. They master 
all the life cycle of a medical device from the idea to the launch of the market. They can lead 
to improve product functionality, usability, safety and quality. We prepare our students to:  
• Medical and biological instrumentation in general, with a special interest for 
Microsystems. The course’s main targets are design enhancement and the development 
of equipment for clinical, medical and biological investigation (biochips, automated 
devices for biological analysis, probes, endoscopes, artificial organs and systems for 
physiological assistance etc…).  
• The analysis, design and development of biomechanical systems. They thus receive 
special training on mechanical design, manufacturing engineering, and special training 
on materials used in surgery (metal, polymer, ceramic, composite…) as well as their 
different use in biological environments, ie tissues and human organs 
(biocompatibility). The main applications are orthopaedics (prosthesis and orthesis). 
Our students play a significant role in emergence of combination products (e.g. biologic and 
device or drug and device). 
www.intechopen.com
 
Biomedical Engineering – From Theory to Applications 
 
158 
1.1 11 months’ work experience 
Training periods and projects in laboratories, in health services or in companies enable 
ISIFC trainees to acquire practical experience, and to communicate with all the actors of the 
biomedical sector. 
During the second year, all the students are invited to have a 6 weeks work experience 
(February and March) at the hospital. It enables future engineers to fully grasp the 
integration of biomedical equipments within a health service, from a technical and human 
point of view. 
During their third year (master degree), students are challenged through a development 
project. It lasts 3 months (December to February), and the project is addressed individually. 
Projects may be done at a private company or at a public research department. 
A working period in a company premises concludes the 3-year course. It lasts from 16 weeks 
up to 24 weeks (March to September). Industrial trainee engineers take on missions that are 
usually assigned to junior engineers within a firm. 
The ISIFC engineers’ specificities are their good knowledge in regulatory affairs and in the 
quality aspects of the technologies of health, their analysis of benefits/risks for the patient 
and the pre clinical investigations they can manage. In it is added strategies of tradition 
from Franche-Comté as mechanical/biomechanical, medical instrumentation and 
microtechniques.  
ISIFC engineers master regulatory and clinical affairs. At the end of the training, they are 
able to elaborate the technical file indispensable for the CE mark and FDA and so for the 
launch of the European and American market. They can design and create medical 
devices.  
In fact, ISIFC School is an important partner for medical device technology development 
and evaluation process. ISIFC is also a tool of effectively surveying prospective device users. 
These users are healthcare professionals, patients, elderly people or people with disabilities, 
researchers and industrials. 
1.2 Why Biotika®? 
To stimulate greater academia/business interactions, in 2006, ISIFC created Biotika®, a 
virtual company (without legal status) specialized in design engineering of innovative 
medical devices. ISIFC created an environment for innovation in healthcare to stimulate 
commercialization of new medical device, to reduce costs and to deliver faster. Marketing, 
regulatory and clinical affairs, service support, accounting and inventory are concerned (no 
manufacturing and no production engineering). This company was built on the basis of a 
training module at the end of 2nd year (75 hours per student) and in the beginning of the 
third and last year (100 hours per student). It’s not only an educational entrepreneurship 
exercise to encourage students during their university programme. The purpose is to make 
discover to the pupils engineers the various facets of their future job with a real professional 
overview and to establish real new innovative businesses enhancing the research academic 
researchers or supporting real start up activities. Biotika® is guaranteeing quality 
throughout its organization and is systemising quality within the organization (according 
ISO 13 485). The idea is to sensibilize the students to the innovation, the entrepreneurship, 
the quality approach, and the project management with specific angles to the regulatory 
affairs, clinical investigations, the financing of the innovation, the industrial and intellectual 
properties and the market studies. 
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The goal of this chapter is to show how was built inside ISIFC a “catalyst” and performing tool 
for the innovation and the partnership research. Biotika® is in fact a cell of pre incubation of 
technological projects for the health, stimulating proof of concept and development of new 
ideas arising from patients, physicians, surgeons, universities and industrials. 
An experience feedback of 5 years will be described. The virtual company works on 
development projects and transfers of medical devices, and is in fact real cell pre incubation. 
The chapter describes its collaboration in the creation of start up Cisteo MEDICAL 
(incubator Franche-Comté). It gives three examples, financial supported by OSEO and 
Besançon University valorisation maturing process. Different applications domains are 
concerned: maxillofacial surgery, dental surgery, oncology, palliative care, gastroenterology 
and cardiovascular diagnosis. Very recently, Biotika® obtains financial support from the 
French Agency of Research (ANR program Emergence) with innovative saliva substitute 
technique for maxillofacial surgery.  
2. General Biotika® principle 
The nature of this innovative concept is based on the originality of the ISIFC School. It’s the 
heart of an innovative process to accelerate device deployment in the market. It’s required 
strong interactions among academia, life sciences, technology, engineering and industry. 
The pupils-engineers recruited in Biotika® (about 20 a year) work one-two days a week on 
real projects and according ISO13485 standard. Three permanent members pilot the virtual 
company. They are punctually assisted by university experts, secretary finance and by a 
technician in electronics. The CEO of Biotika® is guiding in reality ISIFC and is also 
associate professor in optoelectronics. The Human Resources manager is in fact an associate 
professor in electronics and educational responsible of this training unit. The QA and 
regulatory affairs manager is a half time teacher but also Quality manager in a biomedical 
industry Statice Santé, ISIFC partner. The director of CIC-IT (Clinical Investigation Center-
Innovation Technology) of Besançon Hospital collaborates regularly with Biotika®. 
Every year, a new project is developed. The students participate with the staff to the choice 
of the new maturation. This general brainstorming (4 hours) is just after their six weeks 
hospital internship. 
Different scenarios are possible:  
• development of a medical device new to the market 
• major upgrade of an existing medical device after a regulatory affairs modifications or 
after device deployment in the market and first users feedbacks  
• re-design of a device prototype  and regulatory affairs optimisations. 
3. Biotika® partnership arrangement and network 
Biotika®, pre-incubation cell of technology projects for the health of the ISIFC is in fact a tool 
catalyst for innovation and research partnerships. All of partners are important and we have 
a complementary network. They need to interact with and to learn from each other. 
The three permanent members of the ISIFC Biotika® (CEO, Director human resources and 
Director Quality / Regulatory Affairs) are full time university assistant professor. The 
director of the Besançon CIC IT, physician of CHU, participates regularly for validation and 
clinical trials.  
The three categories of general customers are: patients, healthcare professionals (nurses, 
biomedical hospital engineers, physicians and clinical researchers) and industrials.   
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Four categories of customers have significant influence in the decision to innovate in the 
company. Firstly there are ISIFC students. The second category is prescribers (physicians, 
manage care organization and hospitals). The third category consists of the payers and 
policy makers. The last but not least category is the Biotika® permanent staff (teacher and 
researcher). 
Biomedical engineering students recruited Biotika® work every year on real projects, 
detected during hospital internship and serving clinicians and patients. It’s in close 
collaboration with research laboratories of the UFC and businesses Franc-Comtois. 
Due to ISIFC links to established research laboratories in the field of engineering, micro-
technologies or health (about 30 laboratories and research centres are worldwide known and 
associated to National Research Centres such as CNRS and INSERM), each student benefits 
from the most recent scientific and technological innovation and  has access to up to date 
equipment available in these units. We work particularly with the scientific group 
specialized in engineering and innovative method for health (GIS) [FEMTO-ST 6174 CNRS 
Institute (with the French label Carnot “ability to conduct research with industrial partners), 
IFR 133 INSERM institute and LIFC informatics research laboratory].  
The University of Franche-Comté established a Valorisation Administration in 1997 in order to 
develop in the institution a culture of partnership with the socio-economic environment, and 
to support laboratories in the valorisation process of their research results. To support this 
move, a SAIC (Department of Industrial and Commercial Activity), which is a valorisation 
management tool, was set up in 2004. An annual maturation process, called “Maturation 
Franche – Comté” was set up at the University of Franche-Comté thank to the ANR 2005 
program. Biotika® has succeeded 5 times to benefit of this kind of financial process (Fibrotika 
in 2006, Physiotika® in 2008 and 2009, S-Alive in 2010, AgiMilk in 2011). 
The Clinical Investigation Centre – Technological Innovations of Besançon (INSERM CIT 
808) is located in and managed by Besancon University Hospital and INSERM as co-
manager. The Clinical Investigation Centre is approved by INSERM and the DHOS for two 
activities: biotherapies (CIC-BT approved in 2005 and reconducted in 2010) and 
Technological Innovation (CIC-IT approved in 2008). The CIC-IT is already implied in 
medical devices development through ANR and OSEO programmes and translational 
research. The institute collaborates with the environmental platform MicroTech-hosted by 
the Health institute of technology transfer of Franche-Comte (Institut Pierre Vernier).  
 
 
Fig. 1. MicroTech platform principle 
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Our virtual firm collaborates with the incubator in Franche Comté. Christophe Moureaux, a 
senior engineer, joined the incubator in December 2009 to set up a company (Cisteo 
MEDICAL) dedicated to the development and manufacture of new medical devices 
combining established material, associated motor units, sensors and embedded energy, in 
partnership with the ISIFC and Biotika® and the University Hospital of Besançon. This start 
up is now supported by OSEO. The further development of the devices pre incubated by 
Biotika® will be provided later with Cisteo MEDICAL by consortium.  
Biotika®, virtual firm, develops real active partnerships with industrial actors: Cisteo 
MEDICAL but also Alcis, Covalia, Statice and Technologia. This industrial partnerships’ list 
is undergoing constant. Franche-Comté lies at the heart of Europe, a region in the east of 
France.  The border between Franche-Comté and Switzerland is 230 km long. It’s an 
important factor of our biomedical industrial network’s success. 
4. Virtual company structure 
The "virtual company" works with French collective agreements 3018 but without legal 
status. The legal status is in fact a university status. The activity is only on 2 days per week 
and only during 7 months per year. It’s in fact an innovative educational concept with focus 
on real medical devices’ conception. The trademarks are INPI registered. 
In 2006, students enrolled and whose names are designated in part N°16 in thanks, created 
all together and in total autonomy (but after validation of management) all communication 
tools. For example, they create their company name and logo (fig. 2) which were INPI 
registered in 2007. Now, it’s the same process for new products’ names. Physiotika® in 2008, 
S-Alive® in 2009 and Agimilk® in 2010 names were INPI registered. 
 
 
Fig. 2. Logo of our virtual company is INPI registered 
The Biotika®’s website is http://biotika.adeisifc.fr/ 
The webmaster is a student. 
5. Management principle 
5.1 Innovative principle  
Further to the hospital training course (6 weeks), the new members of Biotika® decide 
together on new projects they want to develop. The objective is to innovate, that means to 
develop at least one innovative medical device per year. Since its creation, 8 projects were 
pre incubated. We want essentially to work for patients who are affected in terms of their 
quality of life and a significant reduction in their disability. 
5.2 Steps principle 
Principle is described on figure below. We have five steps and two phases during half year 4 
and half year 5: 
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1st phase : half year 4 
 
 
2nd phase : Half year 5 
 
Fig. 3. Management principle during the two semesters, half year 4 and 5 
Mission
Form Mission 
Form 
Mission
Form
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• Detection of needs (after hospital internship) Definition of functional specifications, 
bibliographic research, relevant economic and clinical benefit / risk  
• Research evidence, experiments and simulations of feasibility, design demonstration 
models of preclinical protocols and files for CE marking, removal of the first scientific 
obstacles  
• Research funding, confidentiality agreements and partnership  
• Launch of joint development and validation of preclinical  
• Transfer to real companies in the manufacture of prototypes and pre-industrial to 
industrial  
6. Organizational structure  
Biotika® team for 2006 was initially made up of thirteen people, including eleven ISIFC 
engineering students (see list in Part 16, Acknowledgements). Every year, Biotika® staff is 
completely renewed. All the posts (except management) are attributed to the new pupils-
engineers of the 2nd year of ISIFC. They are really interviewed by professional people.  
In 2007, the team organization changed. It consisted of eighteen people, including fourteen 
engineering students ISIFC sometimes with double missions. A department Quality / 
Regulatory Affairs / Marketing / Communication was created. Technical Director (half part 
time Human Resources Director) droved three different projects (CP 1-3) and the purchasing 
manager logistics. Most of them worked in project team (a team leader with R&D engineers 
by project). Some of them worked with transverse missions or with specific responsibilities 
(purchase, communication, regulatory affairs, quality, marketing, supplier quality 
assurance, clinical investigations).  
 
 
Fig. 4. Biotika® 2008 team  
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In 2008, the Biotika®’s team (Fig. 4) was composed of 30 persons, including twenty-one 
students ISIFC engineers. The direction of Biotika® included additional permanent 
members: a doctor of hospital university CIC-IT department (Dr. Lionel Pazart) as director 
clinical investigations (DIC), four project managers (DP1 to DP4, Georges Soto Romero, 
Fabrice Richard, Sébastien Thibaud and Sébastien Euphrasie are all teachers and researchers 
of FEMTO-ST CNRS laboratory). Each tutorial provides a close with the respective project 
manager. The new interviews of the virtual firm are outsourced over Statice Santé Company 
and Témis Institute. It tooks place in Besancon in April 2008 to allocate to each its place 
within the virtual company and to fill a number of new missions related to the following 
positions:  
• Four project leaders, CP1 to CP4  
• Research and Development Engineers,  
• Logistics & Purchasing Manager, RAL  
• Communications project manager, RCP  
• Communication / Marketing, RCM  
• Quality Manager, RQ  
• Regulatory affairs Manager, RAR 
• Quality assurance manager with suppliers, RAQF  
• Product qualification engineer, IQP 
• Information system engineer-collaborative platform and internal communication, 
ISIC 
• Clinical testing and validation engineer, IEVC.  
The offices of Biotika® are located in the premises of ISIFC in Besançon. Their members 
have access to the technological and logistical resources of FEMTO-ST, University of 
Franche-Comté, ISIFC, Besancon Hospital and CIC-IT. A platform of engineering 
collaborative allows a technical partnership with schools of Morteau and Dole. We work 
nearby the IUT (University Institute of Technology) in mechanical engineering as well as the 
AIP Primeca of Besançon. Thus, all pieces are manufactures in Franche Comté region.  
A PLM tool is used to share the different documents generated by the students during the 
R&D process.  
 
`   
Fig. 5. ISIFC/Biotika® building located on TEMIS Park and managing revue meeting 
Now, managing director uses a cross matrix described bellow.  
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The legend is for the permanent staff:  
NB : N. Butterlin, GSR : G. Soto Romero, FG : F. Guyon, LP : L. Pazart, ST : S. Thibaut, SE : S. Euphrasie, 
JD : J. Duffaud, FR : F. Richard, [CG] : C. Garcia. 
The general organization is composed of permanent staff and there is one project manager by project. 
All the others functions are assumed by students. Their number depends on complexity and project. 
There are mechanical and electronical R&D engineers’ teams. 
Fig. 6. Crossed matrix, organization chart functional 
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7. Innovative active training  
7.1 Missions of the training module 
This is, in a virtual firm, to create and maintain a dynamic coaching and collaborative work 
that gives students opportunities for implementation of academic knowledge in biomedical 
engineering. The purpose is to provide students and this during their training, a scenario 
first real experience "tutored" and participative management style. They discover in their 
future learning progressive industrial activities.  
This allows students in terms of autonomy, initiatives and recovery: 
- To highlight their individual skills (know-how and skills: passion for work and for 
other people especially patients….),  
- To correct their shortcomings and provide a true assessment of skills  
- To involve them fully in the development of image with:  
• Companies in the biomedical sector, 
• Hospital centres,  
• Local, regional, national and international institutions of higher education or 
secondary technical and regional operators,  
• Students from Faculty of Medicine, 
• Patients associations. 
- To have ideas for innovation  
- To be able to develop innovative medical devices 
After the module, they know that innovation takes a lot of time, a lot of energy, a lot of 
creativity and needs strong interactions between mentors, mentees and many others. 
7.2 Resources available  
This module is expected late in the second year (semester N°4) and the beginning of the 
third (semester N°5). It is built on a base of 7 European Credit Time System (ECTS) or 175 
hours in terms of teaching model. It is divided into two parts: a form of 3 ECTS in 
semester 4 (Number of Hours: 8 h classes, Individual Project Time 67h) and 4 ECTS in 
semester 5 (Number of Hours: 8h classes, Individual project Time 92h). These hours are: 
controlling and monitoring of the "virtual firm", the organization and implementation of 
recruitment in offshore locations, the organization of "events" such as progress meetings, 
quality audits technical and internal customer visits and / or suppliers, participation in 
trade shows ...), organization and implementation of talks progress and interviews. It 
must include a plan for internal training in innovation, clinical trials, programming 
microcontrollers or finite elements, internal auditing, first aid, .... 
The "budget schedule" of compensation for the part of teachers entrepreneurship varies 
from year to year: it partly depends on the training plan (action contractors) and 
"consulting" done by specialists from Biotika®. A "system standby" (on the model of 
hospital guards) is being implemented for the management team and rewarded accordingly. 
The "maximum budget" available for payments of permanent staff and / or individual 
contractor is calculated on the basis of  
1 group / 24 students and 1 group TP / 5 students.  
A teaching group of at least 6 people for the management team and technical supervision is 
necessary for steering Biotika®. It consists of permanent members of the ISIFC who are at least 
one specialist in quality (DQ), a specialist in research and R & D (PDG), a human resources 
manager himself a technical expert (DRH and DT) and a specialist in investigations clinical 
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DIC. The four students project managers (P1 to P4) act as intermediaries between students 
recruited technical and management Biotika® staff. The support by "consultants" in optics, 
mechanical and electronic designs, marketing and business plan (participation of university 
companies’ management school of Besançon), medicine allows students to have recruited ad 
hoc support. The supervision of the training module Biotika® Entrepreneurship is thus a 
specific and custom framing increased. It’s a real experimental innovative educational 
program. 
7.3 Activities associated with the module 
For each project developed, it is:  
Design and implement a technology demonstration vehicle (or functional model) of a 
biomedical device. So get models' skills students ISIFC "for trade shows, national day" 
Celebrate Science "forum of students, JPO ...  
Introduce a quality approach in designing a medical device in collaboration with technicians 
and / or operators, according to the standard ISO 13485. 
Conduct a market analysis and research prior art product.  
Conduct a comprehensive study in order to obtain the CE mark.  
Conduct research and transfer of technological device designed to a manufacturing process 
in collaboration with secondary schools, technical platforms and / or regional IUT.  
Implement corrective action following audits to ensure the quality policy of the company.  
Learn self-assessment and / or evaluate its partners know how to respond to questioning 
skills assessments.  
Learn to understand the needs of businesses in terms of qualifications, with a good-looking 
management of the student's career. 
8. Building the appropriate team and managing people 
Every year, Biotika® renews its staff (excluding permanent management) and no period of 
recovery is possible! A real campaign is organized. The process is conducted with multiple 
conversations between individuals. It’s after Internet publication by firm’s website posting. 
The candidates are selected by pre-processing of curriculum vitae and cover letters in 
French and English. Lasting about one month, ten recruiters are necessary for the 
recruitment operation. This year, 47 candidates are examinated for 23 jobs. Between 
recruiters, they are: manufacturers (and in fact also ISIFC engineer graduated), consultants, 
permanent Biotika®’s staff. The recruitment locations are offshore (business partners or 
local business incubator). All aspects of a job interview are discussed and a response to each 
application is made (the call to service or not, positive / negative). The final allocation of 
posts is based on current skills but also detected (refining the professional project of the 
student). This is the moment to initiate a real active support success.  
In March as is explained in Figure 3, each student turnover, innovative projects are 
proposed and discussed by staff Biotika® (permanent and students). Then, the final choice 
is made by all staff but with a constraint: only one has to be new and innovative. The other 
projects will be developed in continuity with the previous team and with at least one of 
them, specifically oriented biomechanics.  
House training specific to programming microcontroller is available to all. A second phase 
of internal training is then carried out by Internal Audit. 
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Individual interviews with each student assessments, both technical and position are made 
in late June and late November by the N +1 and permanent managers. The rating and 
credits obtained allow validation as an engineer graduated from ISIFC. A review of 
activities, such general meeting and open house, are presented every year in late November 
to the major partners. 
 
 
Fig. 7. Managing revue meeting.  
9. Patenting, trademarks and copyrights 
The patenting and intellectual properties are very important for the general manager of 
Biotika®. The university valorisation framework supports Biotika®’s projects by different 
processes: 
• Negotiating and writing the consortium agreements,  
• Implementing conventions (recruitment, managing expenditure and receipts, sub-
contracting),  
• Following ANR programme implementation  
• Closing conventions and producing administrative items justifying expenses.  
Valorisation University Department ensures in particular that the results of the project are 
protected, if necessary by submitting a patent, as well as commercial valorisation by 
identifying the partners likely to take out user licenses.   
The INPI is the national institute for intellectual and industrial properties registrations. The 
original and innovative concept of our “ISIFC’s virtual firm” can’t patent. But the mark and 
logo of Biotika® are INPI registered on four classes: N° 09, 10, 41 and 42 with specifications 
detailed bellow: 
• Class N° 09: Devices and instrumentations for scientific research in biomedical 
engineering domain. 
• Class N° 10: Devices and instrumentations for surgeons, physicians and biomedicines. 
Beds for healthcare, endoscopes, fibro scopes, saliva automatic distributors…. 
• Class N° 41: teaching and professional training services for biomedical engineering 
students. 
The community law requires a use of the brand «in the life of the business" that means 
according to the community case law «the exercise of an economic activity ", " the offer of 
the goods and the services on a market " or " the exercise of a commercial activity aiming at 
an economic advantage ". The name of the class 41 thus asks question: does the training 
service proposed by the ISIFC raise of the life of the affairs? Yes, because we consider that 
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the training is paying and that there is a "market" of engineering schools (competition to 
recruit the bests "pupils-customers") 
• Class N° 42: Scientific and technologic services for biomedical engineering domain 
(medical devices, instrumentation). Research studies and developments services are 
included. 
Biotika® INPI registered 4 Soleau letters and 3 marks and worked on 4 anteriority studies. 
10. Documentary and communications system  
Within Biotika®, which remains a young company, all the staff is involved in the 
communication strategy of the company. By this approach, the management team expects 
from every student that he learns to communicate with various interlocutors (MD, senior 
engineers and customers). But also, because of the renewal of all the staff from one year to 
the next, the written traceability of all the activities, the technical choices on each project and 
the whole life of the company must be guaranteed by each staff member. 
External communication:  
This requirement justifies our choice of using, more than a web domain (biotika-
isifc.com) in which we can store our website, a new communication and networking 
platform, Agora Project. We found in it a reliable an easy handling tool for collaborative 
engineering. 
Agora project allows sharing all useful information with our different partner, such as 
Morteau and Dole schools (mechanical drawings, printed circuits board designs). In 
that case, Agora is used as a powerful external communication tool. 
Internal communication:  
Agora project is also an internal communication tool, used as same as an intranet. 
Memorandums, agendas and meeting reports are uploaded and shared with all the staff. 
The quality system of Biotika® requires a lot of data records. We can use Agora Project as a 
distant storage server, and a HR resource tool (for new staff members, holidays planning, 
etc). 
Best results : 
This network based communication system help to increase our productivity. Also, our 
students were able to contribute on scientific production (papers, posters) related with each 
project and with the firm. In the other hand, they could participate on several meetings like 
Micronora (3 times since 2006) and MEDTEC France (2 times since 2010).  
11. Quality management system 
11.1 Quality policy  
In addition to train students for the workplace, Biotika® has its own goals as a company 
whose virtual goal is to improve the lives of patients:  
- Develop and implement innovative medical devices,  
- Establish a quality system for the company according to ISO 13485,  
- Conduct a technical file on each product,  
- Assume the investigations and clinical trials for a CE  
- Ensure internal / external communication of the company, market analysis  
- Managing the company in its entirety: budget, employment contracts, quality audit, 
meetings with industry, intellectual property, ...  
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- To transfer the concept to an academic or industrial partner able to guarantee 
production (mission partnership, quality file) or create a real business. 
The quality process unfolds within any organization Biotika® (structure documentary 
records in relation to the requirements of ISO 13485). Every years, actions are validated 
through an internal audit carried out in the end of annual activity. 
 
 
Fig. 8. Quality policy of Biotika® 
11.2 Processes and mapping 
At the beginning, the main important step was to identify the customers and their 
expectations. It was not simple to define the main customers to satisfy. The direction 
decided to satisfy in first the student themselves. 
One of the first actions initiated by the student was also to identify the processes which 
would have an impact of the customer’s satisfaction. For them, there were 2 main 
activities: 
- Communication : in order to become known Biotika® 
- Design : in order to develop the innovative medical device chosen 
To monitor these 2 processes, a management process is there to define the policy, to engage 
the corrective and preventive actions, to audit the system in place and to review at an 
adequate frequency the aptitude of Biotika® to meet customer’s requirements during 
managing review. 
Quality Policy of Biotika® BIOTIKA® aims at developing medical devices and improving the industrial and academic partnership. Also Biotika® makes a commitment: 
- To implement a case study  
- To reach the missions defined at the beginning of the project 
- To give a new approach of the entrepreneurship 
- To implement the engineer’s sciences learned during the year 
- To allow the students to integrate the industry dimension 
- To transfert the knowledge to the following promotion and so to maintain a dynamic within ISIFC 
- To facilitate the professional insertion  
- To implement the partnership with local schools 
- To insure the recognition of BIOTIKA® by the professional of the biomedical area and by the local authorities As managing director, me, Nadia Butterlin, I make a commitment to give all the resources necessary for the good functioning of BIOTIKA®. In order to meet all biomedical industry aspects, I named a quality manager who is in charge of the Quality Management System according to the ISO 1͵Ͷ8ͷ standard.   Nadia Butterlin Managing Director 
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And to support the realization processes, some activities were precised as: 
- Documentation management 
- Purchasing actions 
- Incoming inspection  
- Measuring instruments monitoring 
- Regulatory survey 
The students after the processes identification decided to map them in order to define the 
interfaces between each process. 
Another important action was to define the documentation (describe all the procedures of 
the quality system) and the record necessary to prove that the activities are implemented 
according the quality system in place. 
An internal audit is performed every year and two management reviews are led to insure 
that the system of quality management is conform to the ISO13485 standard. The 
implemented actions are reviewed and also the objectives. The evaluation of the 
“employees” validates the obtaining of the engineering degree of ISIFC.  
You can find below the map which is also in the Quality Manual 
 
 
Fig. 9. Quality Map 
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12. Maturing projects’ story 
Within Biotika®, two products were developed in 2006: a bed voice-activated and an 
automated flexible endoscope. This year, there are five different projects. 
 
 
Fig. 10. Manufacturing plans exhibited at Micronora 2006 
 
 
Fig. 11. Working model exhibited at Micronora 2006 
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12.1 Hospital bed with voice recognition  
The concept is based on the instrumentation of a motorized hospital bed to a patient or the 
caregiver to control the position of the bed by voice recognition. Instructions, recorded in 
advance, allow engines to operate the corresponding control. Possible instructions are "up" 
and "down". They can then be combined with "whole", "head" and "feet". To ensure the 
functionality of the bed, an alternative means by remote control manual has been planned.  
A working model shown in Figure 10 and based on the principles outlined above was 
performed.  
12.2 Automated flexible endoscope  
The concept is based on remote instrumentation, using a joystick and miniature motors, 
displacement of the head of a video endoscope (a variety of flexible endoscope) which is 
used in the exploration of some cavities body and the taking of samples. To date, this shift is 
based on mechanical action at the end of an endoscope through knobs. A wheel provides the 
lateral movement of the endoscope head and the other the vertical displacement, which 
makes the system cumbersome. However, this system has many disadvantages for the user. 
Originally intended to be manipulated with one hand (while the second deals with the 
insertion and withdrawal of the endoscope), this is not the case in reality. Indeed, it is found 
to be extremely difficult to use simultaneously, with ease and precision, the two control 
knobs with one hand. 
There are two solutions to the practitioner:  
- Use both hands to control, requiring the presence of a third hand for insertion and 
withdrawal of the endoscope (nurse)  
- Or use only one of two dials (most accessible) with one hand and rotate the 90 ° 
endoscope to access the other direction.  
 
 
Fig. 12. (a) Head of the endoscope control ,(b) Model of the proposed handle with joystick, 
(c) handle being designed  
(a) 
(b)
(c) 
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If, to maintain total control of the procedure, experienced practitioners have mastered the 
second method presented above, this is not true of young interns who need lots of practice 
before they can act alone. This problem of handling the endoscope, it is clear: an increase in 
the time of the intervention, a greater risk of irritation or perforation of the walls for patients 
(especially during this period of learning internal) and an increase in the learning period of 
the endoscopic technique.  
This study on improving the ergonomics of flexible endoscopes has led to Biotika® proposes 
as a solution to automate the order. 
A feasibility study was undertaken in partnership with the Division of Gastroenterology 
CHU Besançon and Dr. Stéphane Koch. A first demonstrator has been realized in 2006. 
In 2007, the new team has developed the product automated endoscope, Fibrotika renamed, 
and worked in parallel on two new projects: Visiotika, a device for visual control interface 
for controlling the environment for people paralyzed and S-Alive dispensing device of 
artificial saliva for patients with xerostomia (destruction of the salivary glands). 
12.3 Fibrotika: Following the project automated flexible endoscope  
In 2007, Biotika® decided to continue the project renamed Fibrotika automated flexible 
endoscope. The goal is to move from a demonstration model named by students 
Simulscopie at a pre-prototype used for preclinical trials. The tests are scheduled at the 
University Hospital in late 2008 (R&D internship, L.Debar). Contacts with companies 
specialized in the design and manufacture of endoscopes have been established. The ability 
to add sensors at the end of the sheath of the endoscope to create a force feedback on the 
action of the command, and the development of a simulator test to measure efficacy are 
studied. Anteriorities’ research results and the important fund needs are the two major 
reasons to stop the maturation process of Fibrotika inside Biotika®. 
12.4 S-Alive ® 
This project involves the development of a new distributor of artificial saliva for patients 
with Xerostomia (dry mouth sensation) and / or Asialia or oral dryness (lack of or decrease 
in production of saliva). These patients can not produce saliva following a destruction of the 
salivary glands usually secondary to radiation therapy. The result is pain everyday that 
degrade the live of these patients. There are currently sprays and gels to fill the lack of 
saliva, but these solutions do not allow the patient to receive the saliva continuously.  
The anticipated benefits for patients are: greater autonomy, improved quality of life, 
particularly in the context of social life and greater discretion with respect to the other 
people and finally an increased efficiency on oral complications and comfort due to direct 
and regular administration of the substitute on the oral mucosa and dental tissue. 
The main investigator of this project is Dr. Edouard Euvrard (INSERM CIT 808 - IBCT 
INSERM UMR 645). The hospital coordinator manager is Professor Christophe Meyer. He 
supervises research program and he’s Head of the Department of Oral and Maxillofacial 
Surgery at the University Hospital of Besançon. They are responsible for the definition of 
specifications (including the physiopathologic aspects) and the surgical acts during pre-
clinical studies in animals. They are responsible for writing up intermediary reports and the 
final report. The study will take place in the department of maxillo-facial surgery of 
Besançon CHU. The CIC-IT will carry out the necessary administrative steps (writing and 
submitting a file to the committee for the protection of persons in the East of France, for 
example), conducting the study and the statistical analysis of the results. 
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In 2007, project begun with an ISIFC hospital internship. In 2008 and 2009, several steps 
were taken by Biotika®: defining specifications and technical, pre-record risk analysis, 
designing a virtual model in CAD with SolidWorks and SpaceClaim, then building a 
demonstrator incorporating a miniature peristaltic pump alarm with a battery and for filling 
(PCB feasibility demonstrator, see bellow). 
 
 
Fig. 13. Feasibility experimental demonstrator 
A first patent search (December 2006) led to the submission of a Soleau envelope (Dr. 
Edouard Euvrard INPI N°305818, December 6, 2007). Recently, with new patent search of 
March 2010 (ARIST), five competing patents were identified: they are mostly North 
American with one from France. These patents were not considered a threat to our device by 
ARIST. Such a device is not currently on the market and the priority analysis shows that 
freedom to operate and patentability is possible for our idea.  
Before the S-Alive ANR project, which has just started, the valorisation framework had 
already contributed to the realisation of a pre-study, with en amount of 25.000 € through an 
innovating project maturation fund in 2010. This OSEO-Maturation project names 
“Substitution of the insufficiency or absence of saliva in patients suffering from xerostomia” 
and is coordinated between ISIFC/Biotika®, Besancon University Hospital, Department of 
Maxillo-Facial Surgery, CIC-IT, EA4267 Biologic separative sciences and pharmaceutics 
laboratory and Vetagro-Sup animal’s school and its external providers (Cisteo MEDICAL 
and Statice Santé firms). A market analysis is also planned for, as well as the realisation of 
prototype tests on animals to evaluate the risks associated with using this type of device. 
12.5 Visiotika  
This project aims to enable completely paralyzed patients, such as those suffering from 
Locked-In Syndrome, to regain some autonomy by giving them the ability to control their 
environment through their eyes. Currently, such solutions exist but are extremely expensive. 
Biotika 2007 has made such a device at low cost by simply using common materials. Thus, 
Visiotika consists of a webcam connected to a laptop quite commonplace, free software easy 
to use and infrared connections for connecting the PC to control the elements. The 
motivation is to enable patients to purchase this device for their home. The eye movements 
of patients captured by the camera can act on the software as you would with a computer 
mouse. The information is then sent via IR wavelengths to different parts of the patient's 
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environment. Visiotika can control a TV and the hospital bed set up by previous team. It can 
be easily adapted to other applications, such as the opening of electric shutters, turn on and 
off the lights...This project is in stand by for the moment. 
13. Physiotika® project ‘s description  
Physiotika®, was developed to measure pulse wave velocity, a strong predictor of 
cardiovascular risk. This innovative device measures pulse wave velocity by using two 
infra-red probes, placed on two artery sites.  
Increased arterial stiffness is associated with an increased risk of cardiovascular events. For 
example, in patients with chronic renal disease, this risk appears to be far greater than in the 
general population. Several methods are available to determine arterial stiffness, and pulse 
wave velocity (PWV) appears to be the most accurate. The current gold standard to measure 
PWV is through applanation tonometer (AT).  
Non-invasive and predictive of adverse cardiovascular outcomes, this device is technically 
challenging and expensive. However, Physiotika®, a non-invasive method, uses the 
principle of reflectance PhotoPlethysmoGraphy to detect cardiovascular pulse waves. This is 
a common optical technique used to monitor peripheral pulsation. 
The Physiotika® device described bellow is composed of  
• specialized software program (1) 
• housing containing a microcontroller (convert the analogical signal into a numeric 
signal) (3) 
• USB cable to connect the housing to the laptop (2) 
• two infra-red probes (carotid and radial) (4 and 5) 
• neck support to secure the carotid probes (6) 
• wrist support to secure the radial probe (7) 
 
 
Fig. 14. The Physiotika® device 
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Three different Biotika® teams (managed firstly by J.Imbert, secondly by C.Soulaine and 
V.Journot and lastly by B.Jacob) have shown that this new device is able to measure a valid 
index of PWV, as compared to the AT technique in healthy subjects. This project has been 
technically established but requires continued validation in a clinical population. This year, 
we decide to extract this project from Biotika® and to transfer 3 prototypes to researcher 
partners for new international experimentations (in Venezuela and Colombia) and new 
campaigns of data’s collect. 
14. Pre-clinical validations process and regulatory affairs 
In fact, Biotika® is able to conduct: 
• Technical and preclinical studies  
• Technical and preclinical trials 
• Technical and preclinical validations 
An important vigilance is conducted in these phases. 
When we are developing or modifying a medical device, it needs to perform clinical but also 
animal trials to obtain scientific datas that demonstrate the safety and effectiveness of the new 
device. When the device is a class I or class IIa classification, it’s possible to prove these by 
bibliographic data. Biotika®’s team can demonstrate scientific and technical concepts and also 
it can clinical validate the device with simulations and animals trials. We use medical and 
computing data Center and data research Bases of the University. The clinical investigation 
works out a contractual arrangement with the teaching and research Hospital of Besançon 
University (Centre d’Investigation Clinique, CIC).  The CIC sponsor (Doctor Lionel Pazart) is 
responsible for selecting investigators, submits research protocol and human care assurance.  
14.1 Example of Physiotika® Investigations 
This example of investigations are conducted by a student, J.Picouley, during her 3 months 
R&D intership. It was just after Biotika 2009 exercise and a previous 2008 R&D internship 
(N.Mathias). 
It was located in the Clinical Renal Investigation Unit at the Kingston General Hospital 
Satellite Dialysis Clinic, in Kingston (Canada). Trisha Parsons, Assistant Professor, School of 
rehabilitation therapy at Queen’s University was the tutor of this intership. It’s an important  
collaboration with Nicolas Tordi, general coordinator of Physiotika® project. N.Tordi is 
professor at the University of Franche-Comté and works with ISIFC. The purpose of this 
study was to determine the test-retest reliability on healthy volunteers and to perform a 
pilot assessment of the response to change during dialysis. Preliminary results suggest that the 
Physiotika® device may offer a reliable, low-cost alternative for the clinical assessment of 
PWV. 
Renal failure is associated with an increased prevalence of cardiovascular morbidity and 
mortality. Arterial stiffness, as determined by pulse wave velocity, is predictive of adverse 
cardiovascular outcomes such as left ventricular hypertrophy, heart failure, hypertension, 
and cardiovascular related mortality in the population with kidney disease. 
The current gold standard method for assessing arterial stiffness is through the use of 
applanation tonometry. This method is highly skill dependent and results in difficulty 
pooling data from different examiners. Given the logistic considerations with subject 
recruitment, it has been postulated that an alternative method of determining pulse wave 
velocity using infra-red technology, may provide greater inter-tester reliability.  
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14.2 S-Alive example 
The animals’ laboratory, Vetagro Sup in Lyon, works with us for animals trials. If the trial 
doesn’t involve significant risk for patients, a patient consent forms is only necessary to 
collect clinical datas for human use. The trials and validations campaign conduct to the risk 
management report in accordance with regulatory expectations. 
 
 
Fig. 15. Professor C.Meyer, Doctors E.Euvrard and L.Pazart , S-Alive mean coordinators and 
Biotika®’s partners. First tests on animal monitored by Vetagro Sup. 
S-alive project is an active implantable medical devices [AIMD] requiring surgery. Our 
device will be part of the class IIb Rule 8 (EC Directive 2007/47).  Sole responsibility of 
AIMD’s manufacturer is subjected to obtaining the CE mark in "essential conformity" with 
health and safety requirements set by EU directives (93/42 / CE for medical devices 
90/385/EEC). And in this context, the most complex issue in order to obtain the CE mark 
will remain "the risk management analysis" according to EN ISO 14971:2007 which is 
mandatory provision. Biotika®’s team participates to the product development with 
Hospital of Besançon and Cisteo MEDICAL company. The ANR’s purposes program is to 
qualify "the risk / benefit ratio" by referencing all possible risks associated with the physical 
characteristics of the device, its use before and during manufacture, predictable external 
influences, medical or surgical procedures, ionizing radiation (sterilization due to radiation), 
a fault or aging of the device.  
15. Conclusion 
In the scope of a new module, the ISIFC launched in May 2006 its own virtual company, 
named by students Biotika®. Virtual means that this company has no real legal status. It is a 
sort of pedagogic model but on the other hand, the situation scenario for the ISIFC student 
engineers is itself indeed real. They are currently working-in real conditions-on the 
development of new medical devices or on modernization of medical products. The needs 
of these innovative medical devices were identified by the students during their second-year 
(6 weeks) work experience in hospital. Every year, this activity takes place between March 
to December. The end-year students were recruited following an imitation job interview and 
www.intechopen.com
 
Biotika®: ISIFC’s Virtual Company or Biomedical pre Incubation Accelerated Process 
 
179 
each of them was entrusted with a mission (engineer or project manager) in one of the 
company’s four departments; R&D, Quality-regulatory affairs, Clinical investigations and 
Public relations-marketing. Every two days per week and for seven months, the personal of 
Biotika® works on development of innovative medical devices and on the preparation of CE 
marking or FDA. Biotika® developed eight products since 2006. 
Biotika® works on medical devices development projects and on research for patients and 
clinicians. It became in 5 years a real academic pre incubation cell. Firstly, Biotika® was 
awarded a financial prize of 15.000€ by the OSEO Agency and Valorisation Department of 
the Besançon University (maturation funds). It was in June 2006. The youth chamber JCE 
allowed to our virtual firm participating in European competition for the innovative 
company in category INNOVACT Community (Reims, October 2006). We participate every 
year to industrial meetings such as MEDTEC FRANCE and MICRONORA. 
We obtained: 
- In 2009 a real partnership with Besançon University Hospital’s CIC-IT 
- In 2010 a real partnership with Cisteo MEDICAL, start-up created in Besançon  
- By 5 times, financial support given by OSEO/UFC Valorisation Department 
These supports in maturation of innovative projects were intended for the pain and salivary 
disorders treatment, and for the gastroenterology and cardiovascular diagnosis.  
- 5 clinical trials 
- 9 R&D and hospital ISIFC internships  
Recently, the selection to the ANR (National Agency for Research) is going to allow 
developing industrial prototypes of technical substitution of saliva for the maxilla facial 
cancer research with Besançon University Hospital,  EA 4267 Laboratory, Cisteo MEDICAL 
start up and Lyon animals’ school. For this 2010 ANR campaign, only 30 projects are 
selected and obtained 2 years financial support for 271 national candidates. 
For the moment, no Biotika®’s product is still marketed. Two patents are in the course of 
writing, 4 Soleau Letters are INPI registered. The main difficulty is not due to unavailability 
of the students, in contrary! They are principally due to their irregular presence 
(discontinuity in the time) and by students coming from different promotion. And for the 
development of innovative projects, it needs real industrial partnership for a potential 
transfer. Furthermore because the staff is completely renewed, the transfer between the 2 
teams is a critical process and requires a documentary system exemplary.  
Very recently, we obtain funds from Franche Comté Economic Chamber (Intelligence 
Agency) and from University for a real LNE/GMED ISO 13 485 certification. The first audit 
will be in November 2011. 
Three options are selected for Biotika® 2012:  
- keep our original and innovative ISIFC’s university Biotika® virtual company concept 
and move every year new ideas and technology to other partner companies (for 
conventions). 
- actually create a company with the status “Thurs Young Enterprise University” 
(Biotika® 2011 engineering students involved will graduate in July 2012). 
- create a “junior company”with 1901 association legal status and for convention with the 
engineering school ISIFC which currently has 144 students. 
Biotika® is in fact a university structured process for helping patients, clinicians and 
researchers turn a good idea into a viable medical device business.  
Biotika® is not a real firm but it’s a real innovative education program for graduate excellent 
biomedical engineers able to develop real innovative medical device. 
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